PL372288A1 - Sposób wytwarzania chlorku benzoizoksazolometanosulfonylu i jego amidowanie z wytworzeniem zonisamidu - Google Patents

Sposób wytwarzania chlorku benzoizoksazolometanosulfonylu i jego amidowanie z wytworzeniem zonisamidu

Info

Publication number
PL372288A1
PL372288A1 PL03372288A PL37228803A PL372288A1 PL 372288 A1 PL372288 A1 PL 372288A1 PL 03372288 A PL03372288 A PL 03372288A PL 37228803 A PL37228803 A PL 37228803A PL 372288 A1 PL372288 A1 PL 372288A1
Authority
PL
Poland
Prior art keywords
amidation
sulfonyl chloride
methane sulfonyl
benzisoxazole methane
zonisamide
Prior art date
Application number
PL03372288A
Other languages
English (en)
Inventor
Marioara Mendelovici
Neomi Gershon
Tamar Nidam
Gideon Pilarski
Greta Sterinbaum
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of PL372288A1 publication Critical patent/PL372288A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL03372288A 2002-02-22 2003-02-24 Sposób wytwarzania chlorku benzoizoksazolometanosulfonylu i jego amidowanie z wytworzeniem zonisamidu PL372288A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35891602P 2002-02-22 2002-02-22

Publications (1)

Publication Number Publication Date
PL372288A1 true PL372288A1 (pl) 2005-07-11

Family

ID=27766019

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03372288A PL372288A1 (pl) 2002-02-22 2003-02-24 Sposób wytwarzania chlorku benzoizoksazolometanosulfonylu i jego amidowanie z wytworzeniem zonisamidu

Country Status (15)

Country Link
US (1) US6936720B2 (pl)
EP (1) EP1472236A4 (pl)
JP (1) JP2005526049A (pl)
KR (1) KR20040099279A (pl)
CN (1) CN1636002A (pl)
AU (1) AU2003219889A1 (pl)
CA (1) CA2475598A1 (pl)
HR (1) HRP20040766A2 (pl)
IL (1) IL158238A0 (pl)
IS (1) IS7406A (pl)
MX (1) MXPA04008109A (pl)
NO (1) NO20043972L (pl)
PL (1) PL372288A1 (pl)
WO (1) WO2003072552A1 (pl)
ZA (1) ZA200407018B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003298248A1 (en) * 2003-01-10 2004-08-10 Dipharma S.P.A. A process for the preparation of benzo(d)isoxazol-3-yl-methanesulfonic acid and the intermediates thereof
DK1583748T3 (da) * 2003-01-13 2010-04-19 Dainippon Sumitomo Pharma Co Fremgangsmåde til fremstilling af 1,2-dichlorethanfrie krystaller af zonisamid og særdeles rene krystaller af zonisamid
US7081539B2 (en) * 2004-03-25 2006-07-25 Dainippon Sumitomo Pharma Co., Ltd. One-pot process for the preparation of 1,2-benzisoxazole-3-methanesulfonamide
US20060084814A1 (en) * 2004-05-20 2006-04-20 Siva Kumar Bobba V Process for the preparation of zonisamide
US7745471B2 (en) 2004-06-18 2010-06-29 Chemagis Ltd. Derivatives of 1,2-benzisoxazole-3-methane sulfonic acid as novel intermediates for the synthesis of zonisamide
AU2006243000B2 (en) 2005-05-05 2011-05-26 Macrophage Pharma Limited Alpha aminoacid ester-drug conjugates hydrolysable by carboxylesterase
WO2007016209A2 (en) * 2005-07-28 2007-02-08 Teva Pharmaceutical Industries Ltd. Pure 1,2-benzisoxazole-3-methane-sulfonic acid sodium salt and purification process
WO2007016208A2 (en) * 2005-07-28 2007-02-08 Teva Pharmaceutical Industries Ltd. 1,2-benzisoxazole-3-methane-sulfonic acid ammonium salt
US7268234B2 (en) * 2005-09-16 2007-09-11 Dainippon Sumitomo Pharma Co., Ltd. Method for sulfonation of 1,2-benzisoxazole-3-acetic acid
US7375233B2 (en) 2005-12-16 2008-05-20 Apotex Pharmachem Inc. Process for the preparation of zonisamide and the intermediates thereof
CN102329278A (zh) * 2010-07-13 2012-01-25 深圳市资福药业有限公司 一种唑尼沙胺晶体、其制备方法和包含其的药物组合物
KR102704441B1 (ko) * 2016-11-25 2024-09-09 삼성디스플레이 주식회사 증착용 마스크, 이의 제조 방법, 표시 장치의 제조장치 및 표시 장치의 제조 방법
CN106810507B (zh) * 2017-01-23 2019-06-21 珠海市海瑞德生物科技有限公司 一种唑尼沙胺的绿色环保合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6033114B2 (ja) 1976-12-16 1985-08-01 大日本製薬株式会社 1,2−ベンズイソキサゾ−ル誘導体
US4172896A (en) * 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
DE3884966T2 (de) * 1987-12-29 1994-02-03 Dainippon Pharmaceutical Co Mittel zur behandlung der ischämischen gehirnkrankheit.
CA2440030A1 (en) * 2001-03-02 2002-09-12 Teva Pharmaceutical Industries Ltd. Process for the preparation of 1,2-benzisoxazole-3-acetic acid
IL158239A0 (en) * 2001-08-30 2004-05-12 Teva Pharma Zonisamide intermediate and synthesis

Also Published As

Publication number Publication date
WO2003072552A1 (en) 2003-09-04
WO2003072552A8 (en) 2004-09-23
US20040014983A1 (en) 2004-01-22
IL158238A0 (en) 2004-05-12
CN1636002A (zh) 2005-07-06
EP1472236A4 (en) 2006-04-19
IS7406A (is) 2004-08-17
HRP20040766A2 (en) 2005-02-28
EP1472236A1 (en) 2004-11-03
AU2003219889A1 (en) 2003-09-09
CA2475598A1 (en) 2003-09-04
MXPA04008109A (es) 2004-11-26
JP2005526049A (ja) 2005-09-02
NO20043972L (no) 2004-09-22
ZA200407018B (en) 2006-06-28
KR20040099279A (ko) 2004-11-26
US6936720B2 (en) 2005-08-30

Similar Documents

Publication Publication Date Title
EP1867939B8 (en) Apparatus for the liquefaction of natural gas and methods relating to same
GB2408334B (en) Single phase sampling apparatus and method
EP1576033A4 (en) PROCESS FOR PRODUCING POLYSILOXANES AND USE THEREOF
GB2395210B (en) Apparatus and methods to complete wellbore junctions
GB0325192D0 (en) Method of use
PL374126A1 (pl) Sposoby i kompozycje do leczenia reperfuzji niedokrwiennej
GB0120272D0 (en) Improved process for liquefaction of natural gases
IL158238A0 (en) Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide
GB0307986D0 (en) Provision of commands to computing apparatus
EP1630791A4 (en) SPEECH SYNTHESIS DEVICE, SPEECH SYNTHESIS METHOD, AND PROGRAM
EP1644071A4 (en) METHOD AND DEVICE FOR SUPPLYING GAS TO A FIELD
EP1613338A4 (en) TAMANDARIN ANALOGUES, FRAGMENTS THEREOF AND METHODS OF MAKING AND USING THE SAME
ZA200510330B (en) Novel method of synthesising perindopril and the pharmaceutically-acceptable salts thereof
EG26629A (en) A new process for the synthesis of pyridopril and its pharmaceutically acceptable salts
GB0517926D0 (en) Human machine interface for instruments and method to configure same
ZA200601426B (en) Novel method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof
PL379629A1 (pl) Nowy sposób syntezy perindoprylu oraz jego farmaceutycznie dopuszczalnych soli
PL379628A1 (pl) Nowy sposób syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli
PL380410A1 (pl) Sposób syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli
GB0220735D0 (en) Innoculation method and related apparatus
MXPA02004180A (es) Metodos de sintesis de dl-hidroxi-alquil-fenil amidas.
AU2003272390A8 (en) Ampds as modifiers of the p21 pathway and methods of use
GB2441840B (en) Process for the synthesis of arylfluorenes and analogues thereof
GB0400840D0 (en) Method of processing oscillatory data
GB2398624B (en) Process for the removal of the hydrogen sulfide contained in natural gas

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)